Cargando…

Pharmacogenetics of Antidepressants

Up to 60% of depressed patients do not respond completely to antidepressants (ADs) and up to 30% do not respond at all. Genetic factors contribute for about 50% of the AD response. During the recent years the possible influence of a set of candidate genes as genetic predictors of AD response efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crisafulli, Concetta, Fabbri, Chiara, Porcelli, Stefano, Drago, Antonio, Spina, Edoardo, De Ronchi, Diana, Serretti, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108562/ https://www.ncbi.nlm.nih.gov/pubmed/21687501 http://dx.doi.org/10.3389/fphar.2011.00006

Ejemplares similares

Pharmacogenetics of antidepressant response: An update
por: Drago, Antonio, et al.
Publicado: (2009)

Clinical specificity profile for novel rapid acting antidepressant drugs
por: Scala, Mauro, et al.
Publicado: (2023)

Pharmacogenetics and Depression: A Critical Perspective
por: Corponi, Filippo, et al.
Publicado: (2019)

PM449. Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples
por: Porcelli, Stefano, et al.
Publicado: (2016)

Incomplete Coverage of Candidate Genes: A Poorly Considered Bias
por: Drago, Antonio, et al.
Publicado: (2007)

No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression
por: Serretti, Alessandro, et al.
Publicado: (2013)

CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients
por: Drago, Antonio, et al.
Publicado: (2015)

Neural network analysis in pharmacogenetics of mood disorders
por: Serretti, Alessandro, et al.
Publicado: (2004)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors
por: Mandelli, Laura, et al.
Publicado: (2016)

The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?
por: Lippi, Matteo, et al.
Publicado: (2022)

Pharmacogenetic and pharmacogenomic discovery strategies
por: Crisafulli, Concetta, et al.
Publicado: (2019)

Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence
por: Cellini, Lorenzo, et al.
Publicado: (2021)

Insights from pharmacogenetic studies of antidepressants
por: Mandelli, Laura
Publicado: (2010)

Optimization of Antidepressant use with Pharmacogenetic Strategies
por: Torrellas, Clara, et al.
Publicado: (2017)

Social withdrawal and neurocognitive correlates in schizophrenia
por: De Donatis, Domenico, et al.
Publicado: (2022)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Editorial: Innovative treatments for neuro-psychiatric diseases
por: Gozzo, Lucia, et al.
Publicado: (2023)

Imputed expression of schizophrenia‐associated genes and cognitive measures in patients with schizophrenia
por: Fabbri, Chiara, et al.
Publicado: (2022)

The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants
por: Serretti, Alessandro
Publicado: (2018)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
por: Ochi, Taichi, et al.
Publicado: (2021)

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway
por: Cocchi, Enrico, et al.
Publicado: (2016)

The Influence of AHI1 Variants on the Diagnosis and Treatment Outcome in Schizophrenia
por: Porcelli, Stefano, et al.
Publicado: (2015)

Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder
por: Porcelli, Stefano, et al.
Publicado: (2014)

Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality
por: Olgiati, Paolo, et al.
Publicado: (2023)

How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
por: Fabbri, Chiara, et al.
Publicado: (2020)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

No Association of a Set of Candidate Genes on Haloperidol Side Effects
por: Drago, Antonio, et al.
Publicado: (2012)

Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder
por: Yun, Dong-Hwan, et al.
Publicado: (2008)

Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases
por: Serretti, Alessandro, et al.
Publicado: (2007)

Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
por: Bousman, Chad A., et al.
Publicado: (2017)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
por: Mushtaq, M., et al.
Publicado: (2022)

Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder
por: Olgiati, Paolo, et al.
Publicado: (2022)

A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants
por: Kanders, Sofia H., et al.
Publicado: (2019)

In Silico Pharmacogenetics CYP2D6 Study Focused on the Pharmacovigilance of Herbal Antidepressants
por: Don, Charleen G., et al.
Publicado: (2020)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
por: Tuteja, Sony, et al.
Publicado: (2021)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Genetics of Late-Onset Alzheimer's Disease: Update from the Alzgene Database and Analysis of Shared Pathways
por: Olgiati, Paolo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kmcviot9mfhd2f0kj777rhos81